Reports detail gastrointestinal side effects, muscle loss, and safety cautions, underscoring mounting concerns around GLP-1 ...

A groundbreaking investigation has brought to light a notable association between high sugar intake and the risk of ...

HMC s first robotic Whipple surgery was performed on a 42 year old woman diagnosed with a pancreatic head neoplasm. Doha, ...

You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...

A CHILDMINDER who lost 9st from a gastric sleeve and Mounjaro has revealed she was sick every day for a YEAR – but doesn’t ...

MORE than a million Brits will soon be given weight loss jabs on the NHS to slash their chance of suffering a deadly heart ...

Orforglipron is the first new molecular entity cleared under the FDA's Commissioner's National Priority Voucher (CNPV) pilot ...

Announcing a new article publication in BIO Integration. Gallbladder and biliary tract cancers (GBTCs) are highly lethal ...

Novo Nordisk today announced a new multi-month subscription program for Wegovy (R) (semaglutide) that provides eligible self-pay patients who enroll in the program through select telehealth providers ...

Unlike oral semaglutide, orforglipron can be taken without restrictions on food and water ...

Foundayo is now FDA-approved for weight management in adults with obesity or overweight based on the ATTAIN-1 and ATTAIN-2 ...

Some potential non-cardiometabolic benefits lack strong evidence ...